2030’s Top Therapies: Incretin Agonists Loom Large

Mounjaro To Be Highest Selling Drug After Keytruda Biosimilars Debut

 
• By Edwin Elmhirst
  
Competition winners podium 1 2 3
• Source: Enrico Mantegazza / Alamy Stock Photo

More from Growth

More from In Vivo